Pharmacy OneSource Blog

Antimicrobial Stewardship Programs: Moving Towards High Performance

Posted on 02/02/17

The National Strategy for Combating Antibiotic-Resistant Bacteria and subsequent U.S. regulatory movements have moved efforts to establish formal antimicrobial stewardship programs (ASPs) front and center. In the wake of new Joint Commission antimicrobial stewardship requirements and coming mandates from the Centers for Medicare and Medicaid Services, hospitals and health systems increasingly recognize the importance of implementing sustainable strategies. Yet, many lack the resources and know-how needed to move programs from infancy to maturity.

In truth, the business case for investing in a sustainable ASP is an easy one to make. Less than optimal antibiotic prescribing practices—accounting for between 20% and 50% of all antibiotics prescribed in the U.S.—negatively impact both care delivery outcomes and the bottom line. As such, forward-looking healthcare executives are looking closely at the return on investment associated with high-performing ASPs as they prioritize performance improvement initiatives.

In a recently-published Health IT Outcomes article, Steve Riddle, PharmD, BCPS, FASHP, director of clinical development with Wolters Kluwer, Pharmacy OneSource Solutions, outlined five common barriers to high-performing ASPS and how to overcome them. These barriers include:

  • Clinical knowledge
  • Finances
  • Physician Buy-In
  • The right data
  • Infrastructures and tools

The article also speaks to the need for a two-pronged approach that engages process governance and technology-enabled workflows to proactively manage antimicrobial issues. Programs built on the Centers for Disease Control and Prevention’s core elements of an effective ASP and surveillance technology—the infrastructure endorsed by the Center’s for Medicare and Medicaid Services’ Conditions of Participation—provide the framework needed for high performance.

Sentri7® is the KLAS category leader for Clinical Decision Support – Surveillance, with top honors for General Satisfaction, Functionality and Sales/Contracting. The Category Leader in two previous Best in KLAS reports, the solution delivers documented measurable value. For instance, Texas Health Presbyterian Hospital of Dallas leveraged the solution within a high-performing ASP built on industry best practices and decreased broad-spectrum antimicrobial use by 15%, representing a cost savings of $1,621,730 in one year.

 OneSource Clinical Services is also available to fill in the knowledge gaps needed to take ASPs from infancy to maturity. By leveraging the consulting and change management insights of Wolters Kluwer experts, healthcare organizations can jump-start a better strategy.

Contact us today to learn more about how Sentri7™ clinical surveillance system and OneSource Clinical Services equip providers with the infrastructure and expertise needed to achieve a high-performing ASP.

Topics: Antimicrobial Stewardship

About the Author

Deb Oroszlan is the Marketing Director for Pharmacy OneSource - Wolters Kluwer.